C5 and infection: The causes of BTH can be primarily pharmacokinetic, resulting from low or insufficient drug levels that lead to suboptimal complement inhibition, or pharmacodynamic, where infections or other inflammatory conditions trigger (Complement-amplifying conditions or CACs) robust complement activation that temporarily overrides the drug-induced C5 blockade.